Risk Factors Triggering the Development of Preeclampsia in Pregnant Women with Isolated Gestational Proteinuria and Perinatal Outcomes
PDF
Cite
Share
Request
Original Article
P: 255-261
September 2019

Risk Factors Triggering the Development of Preeclampsia in Pregnant Women with Isolated Gestational Proteinuria and Perinatal Outcomes

Med Bull Haseki 2019;57(3):255-261
1. Sağlık Bilimleri Üniversitesi, Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Kadın Hastalıkları ve Doğum Kliniği, Bursa, Türkiye
No information available.
No information available
Received Date: 02.12.2018
Accepted Date: 27.12.2018
Publish Date: 20.09.2019
PDF
Cite
Share
Request

ABSTRACT

Aim:

To determine the risk factors for preeclampsia in isolated gestational proteinuria and to compare perinatal outcomes between women who did and did not develop preeclampsia.

Methods:

Seventy-six pregnants, who were diagnosed with isolated proteinuria between January 2016 and June 2017, were evaluated retrospectively. Data on sociodemographic characteristics, blood pressure and gestational age at onset of proteinuria, the amount of proteinuria, laboratory findings, gestational age at birth, birth weight, mode of delivery, Apgar scores, neonatal intensive care unit admission and perinatal mortality were recorded.

Results:

The incidence of isolated proteinuria was 0.44% (76/17,000). Preeclampsia developed in 18 (23.7%) patients. Systolic blood pressure at the onset of proteinuria was higher in patients with proteinuria and preeclampsia. There was no difference between the two groups in gestational age at birth, birth weight, delivery mode, neonatal intensive care unit admission, Apgar scores, postpartum hemorrhage, cerebrovascular event and maternal death. In logistic regression model, as age (OR=0.749, 95% CI=0.681-0.854, p=0.021) and gestational age at onset of proteinuria (OR=0.632, 95% CI=0.421-0.748, p=0.008) increased, the risk of preeclampsia decreased. Also, logistic regression model revealed that as systolic blood pressure at onset of proteinuria (OR=1.24, %95 CI=1.038-1.254, p=0.014) increased the risk of preeclampsia increased. Moreover, a systolic blood pressure of >122.3 mmHg at onset of proteinuria was found to be a predictor of preeclampsia with a sensitivity of 53.8% and specificity of 77.8%.

Conclusion:

Although favorable perinatal outcomes have been reported, isolated gestational proteinuria is associated with the risk of preeclampsia development. Particularly, in pregnant women with proteinuria detected in early pregnancy and high systolic blood pressure at onset of proteinuria, the risk of preeclampsia development increases. Therefore, patients should be monitored regularly. Considering the fact that we found similar perinatal outcomes between the two groups, we assume that close follow-up of pregnant women with isolated gestational proteinuria is necessary even in the absence of preeclampsia.

References

1Higby K, Suiter CR, Phelps JY, et al. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol 1994;171:984-9.
2American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Report of the ACOG task force on hypertension in pregnancy. Obstet Gynecol 2013;122:1122-31.
3Morikawa M, Yamada T, Minakami H. Outcome of pregnancy in patients with isolated proteinuria. Curr Opin Obstet Gynecol 2009;21:491-5.
4Morikawa M, Yamada T, Yamada T, et al. Pregnancy outcome of women who developed proteinuria in the absence of hypertension after mid-gestation. J Perinat Med 2008;36:419-24.
5Masuyama H, Suwaki N, Nakatsukasa H, et al. Circulating angiogenic factors in pre-eclampsia, gestational proteinuria, and pre-eclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol 2006;194:551-6.
6Magee LA, Pels A, Helewa M, et al. SOGC Hypertension Guideline Committee. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014;36:416-41.
7Magee LA, Pels A, Helewa M, et al. Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 2014;4:105-45.
8Kallela J, Jääskeläinen T, Kortelainen E, et al. The diagnosis of pre-eclampsia using two revised classifications in the Finnish Preeclampsia Consortium (FINNPEC) cohort Kallela et al. BMC Pregnancy and Childbirth 2016;16:221.
9Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 2014;4:97-104.
10NICE Clinical Guideline 107. Hypertension in Pregnancy; The Management of Hypertensive Disorders During Pregnancy. Issued 2010, last modified: January 2011. Available online at:https://www.nice.org.uk/guidance/cg107/resources/guidance-hypertension-in-pregnancy-pdf(accessed September 26, 2015).
11Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-9.
12Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005.
13Yamada T, Obata Yasuoka M, Hamada H, et al. Isolated gestational proteinuria preceding the diagnosis of preeclampsia– an observational study. Acta Obstet Gynecol Scand 2016;95:1048-54.
14Ekiz A, Kaya B, Polat I, et al. The outcome of pregnancy with new onset proteinuria without hypertension: retrospective observational study. J Matern Fetal Neonatal Med 2016;29:1765-9.
15Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1(sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
16Rana S, Karumanchi SA, Lindheimer MD. Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 2014;63:198-202.
17Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet 2010;376:631-44.
18Rana S, Schnettler WT, Powe C, et al. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 2013;32:189-201.
19Holston AM, Qian C, Yu KF, et al. Circulating angiogenic factors in gestational proteinuria without hypertension. Am J Obstet Gynecol 2009;200:392.e1-10.
20Akaishi R, Yamada T, Morikawa M, et al. Clinical features of isolated gestational proteinuria progressing to pre-eclampsia: retrospective observational study. BMJ Open 2014;4:e004870.
21Pettit F, Mangos G, Davis G, et al. Pre-eclampsia causes adverse maternal outcomes across the gestational spectrum. Pregnancy Hypertens 2015;5:198-204.
22Erkenekli K, Iskender C, Oztas E, et al. Clinical, but not laboratory features are predictive of risk of subsequent development of preeclampsia in patients with isolated proteinuria after midgestation. Hypertension in Pregnancy 2015;34:495-505.
23Ohkuchi A, Hirashima C, Matsubara S, et al. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria. Hypertens Pregnancy 2009;28:95-108.
24Shinar S, Asher-Landsberg J, Schwartz A, et al. Isolated proteinuria is a risk factor for pre-eclampsia: a retrospective analysis of the maternal and neonatal outcomes in women presenting with isolated gestational proteinuria. Journal of Perinatology 2016;36:25-9.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House